Tuberculosis is a highly infectious bacterial infection, and is caused due to Mycobacterium tuberculosis or MTB infection and majorly infects human lungs. Tuberculosis (TB) can be caught by breathing in air that an infected person has contaminated through: Breathing, coughing. Furthermore, the disease is ranked second leading cause of death, after human immunodeficiency virus (HIV). Individual majorly suffer from two predominant forms of TB: Active tuberculosis and Latent tuberculosis. The global tuberculosis testing market comprises diagnostic tests, equipment’s and testing procedures that contribute assistance in diagnostic of tuberculosis infection.
The global Tuberculosis Testing market was valued at US$ 2466.8 million in 2023 and is anticipated to reach US$ 2878.6 million by 2030, witnessing a CAGR of 2.2% during the forecast period 2024-2030.
North American market for Tuberculosis Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Tuberculosis Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Tuberculosis Testing in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Tuberculosis Testing include Abbott Laboratories, Akonni Biosystems, Abbott, Becton, Dickinson and Company, Cepheid, Epistem Holdings Plc, F. Hoffmann-La Roche AG, Thermo Fischer Scientific and bioMĂ©rieux SA, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Tuberculosis Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tuberculosis Testing.
Report Scope
The Tuberculosis Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tuberculosis Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tuberculosis Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Akonni Biosystems
Abbott
Becton, Dickinson and Company
Cepheid
Epistem Holdings Plc
F. Hoffmann-La Roche AG
Thermo Fischer Scientific
bioMĂ©rieux SA
Siemens Healthineer
Segment by Type
Smear Microscopy
Nucleic Acid Testing
Radiography
Culture Based Tests
Drug Susceptibility Testing
Others
Segment by Application
Hospitals
Laboratories
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tuberculosis Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tuberculosis Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Smear Microscopy
1.2.3 Nucleic Acid Testing
1.2.4 Radiography
1.2.5 Culture Based Tests
1.2.6 Drug Susceptibility Testing
1.2.7 Others
1.3 Market by Application
1.3.1 Global Tuberculosis Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Laboratories
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tuberculosis Testing Market Perspective (2019-2030)
2.2 Tuberculosis Testing Growth Trends by Region
2.2.1 Global Tuberculosis Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Tuberculosis Testing Historic Market Size by Region (2019-2024)
2.2.3 Tuberculosis Testing Forecasted Market Size by Region (2025-2030)
2.3 Tuberculosis Testing Market Dynamics
2.3.1 Tuberculosis Testing Industry Trends
2.3.2 Tuberculosis Testing Market Drivers
2.3.3 Tuberculosis Testing Market Challenges
2.3.4 Tuberculosis Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tuberculosis Testing Players by Revenue
3.1.1 Global Top Tuberculosis Testing Players by Revenue (2019-2024)
3.1.2 Global Tuberculosis Testing Revenue Market Share by Players (2019-2024)
3.2 Global Tuberculosis Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Tuberculosis Testing Revenue
3.4 Global Tuberculosis Testing Market Concentration Ratio
3.4.1 Global Tuberculosis Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tuberculosis Testing Revenue in 2023
3.5 Tuberculosis Testing Key Players Head office and Area Served
3.6 Key Players Tuberculosis Testing Product Solution and Service
3.7 Date of Enter into Tuberculosis Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Tuberculosis Testing Breakdown Data by Type
4.1 Global Tuberculosis Testing Historic Market Size by Type (2019-2024)
4.2 Global Tuberculosis Testing Forecasted Market Size by Type (2025-2030)
5 Tuberculosis Testing Breakdown Data by Application
5.1 Global Tuberculosis Testing Historic Market Size by Application (2019-2024)
5.2 Global Tuberculosis Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Tuberculosis Testing Market Size (2019-2030)
6.2 North America Tuberculosis Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Tuberculosis Testing Market Size by Country (2019-2024)
6.4 North America Tuberculosis Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Tuberculosis Testing Market Size (2019-2030)
7.2 Europe Tuberculosis Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Tuberculosis Testing Market Size by Country (2019-2024)
7.4 Europe Tuberculosis Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tuberculosis Testing Market Size (2019-2030)
8.2 Asia-Pacific Tuberculosis Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Tuberculosis Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Tuberculosis Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Tuberculosis Testing Market Size (2019-2030)
9.2 Latin America Tuberculosis Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Tuberculosis Testing Market Size by Country (2019-2024)
9.4 Latin America Tuberculosis Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tuberculosis Testing Market Size (2019-2030)
10.2 Middle East & Africa Tuberculosis Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Tuberculosis Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Tuberculosis Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Tuberculosis Testing Introduction
11.1.4 Abbott Laboratories Revenue in Tuberculosis Testing Business (2019-2024)
11.1.5 Abbott Laboratories Recent Development
11.2 Akonni Biosystems
11.2.1 Akonni Biosystems Company Detail
11.2.2 Akonni Biosystems Business Overview
11.2.3 Akonni Biosystems Tuberculosis Testing Introduction
11.2.4 Akonni Biosystems Revenue in Tuberculosis Testing Business (2019-2024)
11.2.5 Akonni Biosystems Recent Development
11.3 Abbott
11.3.1 Abbott Company Detail
11.3.2 Abbott Business Overview
11.3.3 Abbott Tuberculosis Testing Introduction
11.3.4 Abbott Revenue in Tuberculosis Testing Business (2019-2024)
11.3.5 Abbott Recent Development
11.4 Becton, Dickinson and Company
11.4.1 Becton, Dickinson and Company Company Detail
11.4.2 Becton, Dickinson and Company Business Overview
11.4.3 Becton, Dickinson and Company Tuberculosis Testing Introduction
11.4.4 Becton, Dickinson and Company Revenue in Tuberculosis Testing Business (2019-2024)
11.4.5 Becton, Dickinson and Company Recent Development
11.5 Cepheid
11.5.1 Cepheid Company Detail
11.5.2 Cepheid Business Overview
11.5.3 Cepheid Tuberculosis Testing Introduction
11.5.4 Cepheid Revenue in Tuberculosis Testing Business (2019-2024)
11.5.5 Cepheid Recent Development
11.6 Epistem Holdings Plc
11.6.1 Epistem Holdings Plc Company Detail
11.6.2 Epistem Holdings Plc Business Overview
11.6.3 Epistem Holdings Plc Tuberculosis Testing Introduction
11.6.4 Epistem Holdings Plc Revenue in Tuberculosis Testing Business (2019-2024)
11.6.5 Epistem Holdings Plc Recent Development
11.7 F. Hoffmann-La Roche AG
11.7.1 F. Hoffmann-La Roche AG Company Detail
11.7.2 F. Hoffmann-La Roche AG Business Overview
11.7.3 F. Hoffmann-La Roche AG Tuberculosis Testing Introduction
11.7.4 F. Hoffmann-La Roche AG Revenue in Tuberculosis Testing Business (2019-2024)
11.7.5 F. Hoffmann-La Roche AG Recent Development
11.8 Thermo Fischer Scientific
11.8.1 Thermo Fischer Scientific Company Detail
11.8.2 Thermo Fischer Scientific Business Overview
11.8.3 Thermo Fischer Scientific Tuberculosis Testing Introduction
11.8.4 Thermo Fischer Scientific Revenue in Tuberculosis Testing Business (2019-2024)
11.8.5 Thermo Fischer Scientific Recent Development
11.9 bioMĂ©rieux SA
11.9.1 bioMĂ©rieux SA Company Detail
11.9.2 bioMĂ©rieux SA Business Overview
11.9.3 bioMĂ©rieux SA Tuberculosis Testing Introduction
11.9.4 bioMĂ©rieux SA Revenue in Tuberculosis Testing Business (2019-2024)
11.9.5 bioMĂ©rieux SA Recent Development
11.10 Siemens Healthineer
11.10.1 Siemens Healthineer Company Detail
11.10.2 Siemens Healthineer Business Overview
11.10.3 Siemens Healthineer Tuberculosis Testing Introduction
11.10.4 Siemens Healthineer Revenue in Tuberculosis Testing Business (2019-2024)
11.10.5 Siemens Healthineer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Abbott Laboratories
Akonni Biosystems
Abbott
Becton, Dickinson and Company
Cepheid
Epistem Holdings Plc
F. Hoffmann-La Roche AG
Thermo Fischer Scientific
bioMĂ©rieux SA
Siemens Healthineer
Ěý
Ěý
*If Applicable.
